scorecardresearch
Add as a preferred source on Google
Tuesday, March 24, 2026
TopicIndian pharmaceutical

Topic: Indian pharmaceutical

How Indian firm Lupin became the world-leading TB medicine maker

Manish Sabharwal and Sundeep Khanna's 'Made in India' is the untold story of Desh Bandhu Gupta, Lupin, and how India became the pharmacy to the world.

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Trump’s 100% pharma tariffs call for Indian firms to reimagine drug exports. Act quickly

If the US is attempting to force localisation, India should respond aggressively with a proactive agenda. Here’s how.

On Camera

A growing list of scientists is questioning neo-Darwinism

Denis Noble, a fellow of The Royal Society, disagrees with the view of neo-Darwinism that all biological causation stems from the gene.

Blackstone weighs first ever sports investment with IPL bet

The firm has weighed committing $200-$300 million through its Blackstone Private Equity Strategies Fund for two teams, Rajasthan Royals & Royal Challengers Bengaluru.

India-Japan to finalise deal to co-develop & co-produce UNICORN radar ‘soon’, says Japanese envoy

The countries signed a memorandum for co-development of UNICORN masts in November 2024. India has been second Asian nation to have such an agreement with Tokyo, after Philippines.

The Vishwaguru delusion, mine vs yours, is ruining our view of the world

One side thinks India is punching way above its weight. The other thinks Modi has undermined India and it punches below its strength. Both are wrong.